Search clinical trials for: 68Ga-TATE-RGD

Total 5435 results

Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Completed

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Neuroendocrine Neoplasms

Japan
Peking Union Medical College Hospital

Recruiting

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Lung Cancer | Neuroendocrine Neoplasm

China
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Lung Neoplasms

China
Peking Union Medical College Hospital

Recruiting

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

Meningioma | NETs | Iodine-resistant Thyroid Cancer

China
Peking Union Medical College Hospital

Recruiting

177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors

SSTR2 and Integrin αVβ3 Positive Tumors

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients

Breast Cancer

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients

Prostate Cancer

China
Peking Union Medical College Hospital

Recruiting

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Breast Cancer | Prostate Cancer | Brain Tumor | PET/CT Imaging

China
Turku University Hospital
University of Lausanne Hospitals; Leiden University Medical Center

Recruiting

68Ga-NODAGA-RGD PET in Patients With an Occluded Coronary Artery (RGDHeart)

Coronary Artery Disease

Finland, Netherlands, Switzerland
Peking Union Medical College Hospital

Recruiting

Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD

FAP- Expressing Positive Tumors | RGD- Expressing Positive Tumors

China
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies

Tumor

China
Andrei Iagaru

No longer available

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Carcinoid Tumors | Islet Cell (Pancreatic NET) | Other Neuroendocrine Tumors

United States
Rigshospitalet, Denmark

Not yet recruiting

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease

Chronic Ischemic Heart Disease

Denmark
Rigshospitalet, Denmark

Completed

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis

Acute Myocardial Infarction

Denmark
University of Lausanne Hospitals
Swiss Heart Foundation

Recruiting

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

Inflammation | Carotid Artery Diseases | Atheromatous Plaques

Switzerland
Centre de recherche du Centre hospitalier universitaire...
Université de Sherbrooke; Jewish General Hospital

Recruiting

68Ga-DOTA-TATE PET/CT Imaging in NETs

Neuroendocrine Tumors

Canada
Radboud University Medical Center

Completed

RGD PET/CT Imaging in COVID-19 Patients

Covid19 | Endothelial Dysfunction | PET Imaging

Netherlands
Tianjin Medical University
Tianjin Medical University General Hospital

Recruiting

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

Metastasis | Tumor | Positron Emission Tomography | SSTR-related Disease

China
British Columbia Cancer Agency

Not yet recruiting

A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies (NET-COMPARE)

Medullary Thyroid Carcinoma | Pheochromocytoma/Paraganglioma | Neuroendocrine Tumors, NET | SSTR-expressing Tumors

Canada
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction (GRGDMI)

Coronary Artery Disease

China
Peking Union Medical College Hospital
Beijing Tiantan Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma (GRGDG)

Glioma

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients (GRGDLC)

Lung Cancer

China
Huashan Hospital

Recruiting

A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Siemens Molecular Imaging

Terminated

[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

Carotid Stenosis

United States
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis (GRGDRA)

Rheumatoid Arthritis

China
Rigshospitalet, Denmark

Unknown

Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer (RaPiCCa)

Cervical Cancer

Denmark
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke (GRGDS)

Stroke

China
University of Lausanne Hospitals

Terminated

Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

Myocardial Infarction, Acute | Chronic Ischemic Heart Disease | Myocardial Reperfusion

Switzerland
Wuhan Union Hospital, China

Recruiting

Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

Neuroendocrine Tumors | Osteomalacia | PET / CT | PET / MR

China
Rambam Health Care Campus

Recruiting

Sarcopenia in Older Patients in the Acute Hospital Setting

Frailty | Sarcopenia

Israel
Tel Aviv University
Wolfson Medical Center

Completed

Effects of Red Grape Cells (RGC) Powder in Type 2 Diabetics (RGC-T2D)

Type 2 Diabetes

Israel
Central Hospital, Nancy, France

Not yet recruiting

Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement (HemoECMO)

Extracorporeal Membrane Oxygenation Complication | Transfusion Related Complication | Blood Cells Transfusion
The First Affiliated Hospital of Xiamen University

Completed

68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG

Positron-Emission Tomography | Tumor, Solid

China
National Institute of Diabetes and Digestive and...

Not yet recruiting

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Thyroid Cancer

United States
Assistance Publique - Hôpitaux de Paris

Terminated

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents (MLAPOCHI)

Advanced Head and Neck Carcinoma | Advanced Non-small Cell Lung Carcinoma

France
Xijing Hospital

Completed

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Lung Cancer | Lung Tuberculosis
Peking Union Medical College Hospital

Recruiting

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Multiple Myeloma

China
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Terminated

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
Pentixapharm AG

Terminated

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

CNS Lymphoma

Denmark, France
Peking University Cancer Hospital & Institute

Not yet recruiting

68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors

Hepatocellular Carcinoma | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Solid Tumors | PSMA | FAPI
Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-ICAM-1pep PET/CT in Cancer Patients

Cancer

China
Xiangya Hospital of Central South University

Completed

Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013

Gastrointestinal Cancer

China
Novartis Pharmaceuticals

Recruiting

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Non-small Cell Lung Cancer (NSCLC) | Triple Negative Breast Cancer (TNBC) | Colorectal Cancer (CRC) | Soft Tissue Sarcoma (STS) | Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) | HR+/HER2- Ductal Breast Cancer (BC) | HR+/HER2- Lobular Breast Cancer (BC)

Japan
First Affiliated Hospital of Fujian Medical University

Recruiting

The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer

Prostate Cancer (Adenocarcinoma)

China
Memorial Sloan Kettering Cancer Center
Pentixapharm AG

Recruiting

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Multiple Myeloma | Non-Hodgkin Lymphoma | Erdheim-Chester Disease | Rosai-Dorfman Disease | Histiocytic Neoplasms

United States
Yusuf Menda
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Active, not recruiting

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Seoul National University Hospital

Withdrawn

A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Korea, Republic of
Peking Union Medical College Hospital

Recruiting

Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome

Cushing s Syndrome

China
First Affiliated Hospital of Fujian Medical University

Recruiting

Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma

Medullary Thyroid Carcinoma

China
Peking Union Medical College Hospital

Recruiting

Application of 68Ga-Pentixafor PET/CT for Thymoma

Thymoma

China

Search clinical trials for: 68Ga-TATE-RGD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations